Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Postal Realty Trust, Inc. to Report Fourth Quarter 2025 Financial Results on February 24, 2026
-
Getty Realty Corp. Announces Fourth Quarter and Full Year 2025 Results
-
Cipher Welcomes Thomas Duda to the Company’s Board of Directors
-
Iovance Biotherapeutics to Report Fourth Quarter and Full Year 2025 Financial Results and Corporate Updates on Tuesday, February 24, 2026
-
Brilliant Earth to Report Fourth Quarter and Full Year 2025 Financial Results on March 5th
-
BBSI Sets Fourth Quarter and Full Year 2025 Conference Call for Wednesday, February 25, 2026, at 5:00 p.m. ET
-
Vaxcyte Doses First Participants in OPUS-3 Phase 3 Trial Evaluating VAX-31 in Adults Previously Vaccinated with Lower-Valency Pneumococcal Vaccines
-
TTEC Schedules Fourth Quarter and Full Year 2025 Earnings Release and Webcast of Investor Conference Call
-
Universe Pharmaceuticals INC Announces Effective Date of Dual-Class Share Structure
-
Regeneron Announces Investor Conference Presentations
-
BridgeBio Oncology Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
-
Dynagas LNG Partners LP Announces Cash Distribution for the Quarter Ended December 31, 2025 of $0.050 per Common Unit
-
Publication of Interim Condensed Consolidated Financial Statements for the Three and Twelve Months Ended December 31, 2025
-
Crane NXT Announces Fourth Quarter and Full Year 2025 Results; Raises Annual Dividend by 6%
-
Arteris Technology Deployed More Broadly by NXP to Accelerate Edge AI Leadership
-
Intrusion Inc. Launches the P.O.S.S.E. Program, Expanding the Deployment of Shield Technology
-
NETSTREIT Corp. Announces Launch of Public Offering of Common Stock
-
Confluent Announces Fourth Quarter and Fiscal Year 2025 Financial Results
-
Porch Group Reports Fourth Quarter 2025 Results
-
Inspire Medical Systems, Inc. Announces Fourth Quarter and Full Year 2025 Financial Results
-
Outset Medical Reports Fourth Quarter and Full Year 2025 Financial Results
-
Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results
-
AGNC Investment Corp. Declares Monthly Common Stock Dividend of $0.12 per Common Share for February 2026
-
Neurocrine Biosciences Reports Fourth-Quarter and Full-Year 2025 Financial Results and Provides Financial Expectations for 2026
-
Ascendis Pharma Reports Fourth Quarter and Full-Year 2025 Financial Results
-
McDONALD'S REPORTS FOURTH QUARTER AND FULL YEAR 2025 RESULTS
-
Dynex Capital, Inc. Declares Monthly Common Stock Dividend of $0.17
-
VTEX to Announce Fourth Quarter and Fiscal Year 2025 Financial Results on February 26th, 2026
-
PitchBook Introduces the First Daily Valuation Model for VC-Backed Companies
-
Tectonic Therapeutic to Host Virtual KOL Event and Discussion of TX2100, a Novel Approach for the Treatment of Hereditary Hemorrhagic Telangiectasia, on February 24, 2026
-
Magnachip to Announce Fourth Quarter and Full Year 2025 Financial Results on March 4, 2026
-
Carlsmed Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on February 25, 2026
-
AMC Networks Inc. Reports Fourth Quarter and Full Year 2025 Results
-
In HelloNation, Periodontics Expert Dr. Danika Crabtree of Warwick, RI, Explains Why Gum Disease Deserves More Attention Than You Think
-
Birchcliff Energy Ltd. Announces Unaudited 2025 Full-Year and Fourth Quarter Results, 2025 Reserves Highlights and Appointment of Chris Carlsen to the Board of Directors
-
Blend Named a 2026 HousingWire Tech100 Mortgage Award Winner for Seventh Consecutive Year
-
Newell Brands to Present at 2026 CAGNY Conference
-
Stanley Black & Decker To Present At The Barclays 43rd Annual Industrial Select Conference
-
Assured Guaranty Ltd. to Report Full Year and Fourth Quarter 2025 Financial Results on February 26, 2026
-
Destiny Tech100 Inc. Reports Fourth Quarter 2025 Results and New Investments
-
Intuit to Host Investor Day on September 17, 2026
-
Validity Announces Engage, the Next-Generation AI Email Platform to Help Marketers Execute with Confidence
-
Alkermes to Report Fourth Quarter and Year-End Financial Results on Feb. 25, 2026
-
Barzolvolimab Provides Long-Term Improvements for Spontaneous Urticaria
-
Cribl Surpasses $300 million in ARR, Powering the Essential Infrastructure for the AI Era
-
FVCBankcorp, Inc. Announces Completion of $25 Million Senior Notes Offering
-
Biotricity Delivers Strong Q3 Fiscal 2026 Performance, Growing Revenue Momentum and Expanding EBITDA
-
Medical Informatics Corp. (MIC) Welcomes Danielle Russella to Board of Directors
-
Inception Growth Acquisition Limited Announces Extension of Business Combination Period
-
DeFi Development Corp. to Announce Fourth Quarter and Full Year 2025 Financial Results

